These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19337162)

  • 1. Interactions between osteoclasts, osteoblasts and immune cells: implications for the pathogenesis of bone loss in thalassemia.
    Terpos E; Voskaridou E
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():94-106. PubMed ID: 19337162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoimmunology.
    Rauner M; Sipos W; Pietschmann P
    Int Arch Allergy Immunol; 2007; 143(1):31-48. PubMed ID: 17191007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia.
    Voskaridou E; Terpos E
    Br J Haematol; 2004 Oct; 127(2):127-39. PubMed ID: 15461618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taking a toll on the bones: regulation of bone metabolism by innate immune regulators.
    Bar-Shavit Z
    Autoimmunity; 2008 Apr; 41(3):195-203. PubMed ID: 18365832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.
    Takayanagi H
    Nat Rev Immunol; 2007 Apr; 7(4):292-304. PubMed ID: 17380158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the interactions between osteoblast and osteoclast activities in bone remodeling.
    Lemaire V; Tobin FL; Greller LD; Cho CR; Suva LJ
    J Theor Biol; 2004 Aug; 229(3):293-309. PubMed ID: 15234198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major.
    Pietrapertosa AC; Minenna G; Colella SM; Santeramo TM; Renni R; D'Amore M
    Panminerva Med; 2009 Mar; 51(1):17-23. PubMed ID: 19352306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between osteoblast and osteoclast: impact in bone disease.
    Phan TC; Xu J; Zheng MH
    Histol Histopathol; 2004 Oct; 19(4):1325-44. PubMed ID: 15375775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone and its diseases. II. The dialog between osteoblasts and osteoclasts].
    Ziegler R
    Dtsch Med Wochenschr; 1995 Apr; 120(16):571-2. PubMed ID: 7736948
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathogenesis and management of osteoporosis in thalassemia.
    Voskaridou E; Terpos E
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():86-93. PubMed ID: 19337161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoimmunology--the hidden immune regulation of bone.
    Caetano-Lopes J; Canhão H; Fonseca JE
    Autoimmun Rev; 2009 Jan; 8(3):250-5. PubMed ID: 18722561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physiological osteopenia: histomorphometric findings].
    Courpron P
    Rev Fr Gynecol Obstet; 1985 Mar; 80(4):199-203. PubMed ID: 3992119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal dysregulation and bones in thalassaemia--an overview.
    Skordis N; Efstathiou E; Kyriakou A; Toumba M
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():107-15. PubMed ID: 19337163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress in morphology and diagnosis of bone diseases and bone tumors (author's transl)].
    Delling G; Schulz A; Seifert G
    Radiologe; 1976 Feb; 16(2):46-53. PubMed ID: 1257427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bone microenvironment in metastasis; what is special about bone?
    Bussard KM; Gay CV; Mastro AM
    Cancer Metastasis Rev; 2008 Mar; 27(1):41-55. PubMed ID: 18071636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local communication on and within bone controls bone remodeling.
    Henriksen K; Neutzsky-Wulff AV; Bonewald LF; Karsdal MA
    Bone; 2009 Jun; 44(6):1026-33. PubMed ID: 19345750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a traditional Chinese herbal preparation on osteoblasts and osteoclasts.
    Zhang H; Xing WW; Li YS; Zhu Z; Wu JZ; Zhang QY; Zhang W; Qin LP
    Maturitas; 2008 Dec; 61(4):334-9. PubMed ID: 19004583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1.
    Schiltz C; Prouillet C; Marty C; Merciris D; Collet C; de Vernejoul MC; Geoffroy V
    J Cell Physiol; 2010 Jan; 222(1):219-29. PubMed ID: 19780057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of osteonecrosis.
    Jones LC; Hungerford DS
    Instr Course Lect; 2007; 56():179-96. PubMed ID: 17472306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoblasts and osteoclasts in bone marrow smears of cancer patients.
    Gaja A; Churý Z; Hejlová N; Franková H; Macková D
    Neoplasma; 1999; 46(5):313-6. PubMed ID: 10665849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.